Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA clears IND for CYNK-001 in GBM

Jan. 23, 2020

AKCEA-APOCIII-LRx meets primary endpoint in phase II hypertriglyceridemia trial

Jan. 23, 2020

Leo Pharma discovers JAK1 inhibitors

Jan. 23, 2020

Incyte identifies PI3Kgamma inhibitors

Jan. 23, 2020

PTC Therapeutics discloses heteroaryl compounds for Huntington's disease

Jan. 23, 2020

Kinnate Biopharma describes CDK inhibitors

Jan. 23, 2020

Biogen presents new MAP3K5 inhibitors

Jan. 23, 2020

Efficacy of siderophore-antibiotic conjugates in new mouse models of iron overload and depletion

Jan. 23, 2020

Master clock gene keeps macrophages asleep

Jan. 23, 2020

FAM222A raises the risk of Alzheimer's disease

Jan. 23, 2020

Popular Stories

University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Beijing Innocare Pharma Tech discloses new GSPT1 degradation inducers
BioWorld Science
Beijing Innocare Pharma Tech Co. Ltd. has synthesized new antibody-drug conjugates comprising antibody or antigen-binding fragment covalently linked to eukaryotic...